FBIOP
Price
$8.79
Change
-$0.17 (-1.90%)
Updated
Sep 15, 04:21 PM (EDT)
Capitalization
N/A
MLYS
Price
$35.24
Change
-$1.86 (-5.01%)
Updated
Sep 15, 12:32 PM (EDT)
Capitalization
2.88B
57 days until earnings call
Interact to see
Advertisement

FBIOP vs MLYS

Header iconFBIOP vs MLYS Comparison
Open Charts FBIOP vs MLYSBanner chart's image
Fortress Biotech
Price$8.79
Change-$0.17 (-1.90%)
Volume$100
CapitalizationN/A
Mineralys Therapeutics
Price$35.24
Change-$1.86 (-5.01%)
Volume$400
Capitalization2.88B
FBIOP vs MLYS Comparison Chart in %
Loading...
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FBIOP vs. MLYS commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIOP is a Hold and MLYS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (FBIOP: $8.96 vs. MLYS: $37.10)
Brand notoriety: FBIOP and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIOP: 152% vs. MLYS: 82%
Market capitalization -- FBIOP: $0 vs. MLYS: $2.88B
FBIOP [@Biotechnology] is valued at $0. MLYS’s [@Biotechnology] market capitalization is $2.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIOP’s FA Score shows that 1 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • FBIOP’s FA Score: 1 green, 4 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIOP is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIOP’s TA Score shows that 6 TA indicator(s) are bullish while MLYS’s TA Score has 6 bullish TA indicator(s).

  • FBIOP’s TA Score: 6 bullish, 4 bearish.
  • MLYS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than FBIOP.

Price Growth

FBIOP (@Biotechnology) experienced а -2.08% price change this week, while MLYS (@Biotechnology) price change was +6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.74%. For the same industry, the average monthly price growth was +7.59%, and the average quarterly price growth was +34.47%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS YTD gains are higher at: 201.381 vs. FBIOP (34.737). FBIOP has higher annual earnings (EBITDA): -71.92M vs. MLYS (-203.01M). MLYS has more cash in the bank: 325M vs. FBIOP (74.4M). FBIOP has higher revenues than MLYS: FBIOP (59.3M) vs MLYS (0).
FBIOPMLYSFBIOP / MLYS
CapitalizationN/A2.88B-
EBITDA-71.92M-203.01M35%
Gain YTD34.737201.38117%
P/E RatioN/AN/A-
Revenue59.3M0-
Total Cash74.4M325M23%
Total Debt69.2MN/A-
FUNDAMENTALS RATINGS
FBIOP: Fundamental Ratings
FBIOP
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPMLYS
RSI
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 6 days ago
65%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
63%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 12 days ago
65%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGLAX27.41-0.04
-0.15%
American Funds Global Insight R-1
JERCX12.12-0.02
-0.16%
Janus Henderson Global Real Estate C
EGINX36.27-0.08
-0.22%
Invesco International Value Investor
REIFX14.37-0.04
-0.28%
Third Avenue International RE Val Fndrs
ACAEX14.13-0.08
-0.56%
American Century International Gr G

FBIOP and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIOP has been closely correlated with HLVX. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if FBIOP jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIOP
1D Price
Change %
FBIOP100%
-1.65%
HLVX - FBIOP
81%
Closely correlated
N/A
FBIO - FBIOP
39%
Loosely correlated
+1.57%
EVGN - FBIOP
26%
Poorly correlated
+2.42%
MLYS - FBIOP
25%
Poorly correlated
-0.16%
NKTR - FBIOP
25%
Poorly correlated
+3.14%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with CYTK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-0.16%
CYTK - MLYS
53%
Loosely correlated
-4.11%
IONS - MLYS
50%
Loosely correlated
-1.37%
BIESF - MLYS
45%
Loosely correlated
N/A
PTGX - MLYS
39%
Loosely correlated
-1.37%
MNKD - MLYS
37%
Loosely correlated
+2.77%
More